Onconetix Inc.

NASDAQ: ONCO · Real-Time Price · USD
2.92
-0.17 (-5.50%)
At close: Aug 15, 2025, 12:53 PM

Onconetix Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.52M 58.47K n/a n/a
Cost of Revenue
1.47M 1.19M 6.75K 4.89K
Gross Profit
1.06M -1.13M -6.75K -4.89K
Operating Income
-56.49M -36.03M -13.48M -3.42M
Interest Income
18.00 n/a n/a n/a
Pretax Income
-59.74M -37.42M -13.42M -3.42M
Net Income
-58.69M -37.41M -13.42M -3.42M
Selling & General & Admin
11.23M 14.77M 9.35M 2.09M
Research & Development
154.36K 1.95M 4.13M 1.33M
Other Expenses
46.16M 18.19M n/a n/a
Operating Expenses
57.54M 34.91M 13.48M 3.42M
Interest Expense
1.41M 671.63K n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
59.01M 36.09M 13.48M 3.42M
Income Tax Expense
-1.05M -12.59K -61.41K -4
Shares Outstanding (Basic)
32.3K 427.78K 12.27M 10.91M
Shares Outstanding (Diluted)
32.3K 427.78K 12.27M 10.91M
EPS (Basic)
-1.82K -87.6 -1.09 -0.31
EPS (Diluted)
-1.82K -87.6 -1.09 -0.31
EBITDA
-57.6M -36.71M -13.54M -3.41M
EBIT
-58.33M -36.75M -13.42M -3.42M
Depreciation & Amortization
731.35K 43.94K 6.75K 4.89K